Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lubeck

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
International Reviews of Immunology|January 1, 1990
Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigenP K Chanda, R J Natuk, S K Dheer, et al.
Current Opinion in Biotechnology|October 1, 1991
Adenovirus vectors for gene expressionM V Chengalvala, M D Lubeck, B J Selling, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1988
Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectorsP P Hung, J E Morin, M D Lubeck, et al.
The Journal of Infectious Diseases|October 1, 1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzeeK H Hsu, M D Lubeck, A R Davis, et al.
Developments in Biological Standardization|January 1, 1994
Adenovirus vectored vaccinesR J Natuk, A R Davis, P K Chanda, et al.
Vaccine|November 11, 2008
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trialPaul Spearman, Spyros Kalams, Marnie Elizaga, et al.
Nature Medicine|June 1, 1997
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunizationM D Lubeck, R Natuk, M Myagkikh, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirusM D Lubeck, A R Davis, M Chengalvala, et al.
International Reviews of Immunology|January 1, 1990
Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigenP K Chanda, R J Natuk, S K Dheer, et al.
Current Opinion in Biotechnology|October 1, 1991
Adenovirus vectors for gene expressionM V Chengalvala, M D Lubeck, B J Selling, et al.
Virology|April 1, 1990
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinantsP K Chanda, R J Natuk, B B Mason, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1988
Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectorsP P Hung, J E Morin, M D Lubeck, et al.
The Journal of Infectious Diseases|October 1, 1992
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzeeK H Hsu, M D Lubeck, A R Davis, et al.
Developments in Biological Standardization|January 1, 1994
Adenovirus vectored vaccinesR J Natuk, A R Davis, P K Chanda, et al.
Vaccine|November 11, 2008
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trialPaul Spearman, Spyros Kalams, Marnie Elizaga, et al.
Nature Medicine|June 1, 1997
Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunizationM D Lubeck, R Natuk, M Myagkikh, et al.
Pageof 5